Strontium-substituted apatite coating grown on Ti6Al4V substrate through biomimetic synthesis

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 83, Issue 1, 2007, Pages 258-265

  Oliveira, A L ^a,b   Reis, R L ^b   Li, P ^a  

^a Synthes Technical Center   (United States)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

Apatite coating; Biomimetic synthesis; Calcium phosphate; Strontium (ion substitution); Titanium (alloys)

Indexed keywords

BIOMIMETICS; BONE; IMPLANTS (SURGICAL); STEREOCHEMISTRY; STRONTIUM; TITANIUM ALLOYS;

APATITE COATING; BIOMIMETIC SYNTHESIS; OSTEOINTEGRATION;

APATITE;

APATITE; CALCIUM; CALCIUM PHOSPHATE; NANOMATERIAL; STRONTIUM; TITANIUM;

ARTICLE; BIOMIMETICS; BONE REGENERATION; CHEMICAL STRUCTURE; IMPLANT; JOINT PROSTHESIS; KINETICS; MATERIAL COATING; MEASUREMENT; MINERALIZATION; OSSIFICATION; STEREOCHEMISTRY; SYNTHESIS; TECHNIQUE; THICKNESS;

ANIMALS; APATITES; BIOMIMETIC MATERIALS; BIOMIMETICS; BIOREACTORS; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; MATERIALS TESTING; PROSTHESES AND IMPLANTS; STRONTIUM; TITANIUM;

EID: 34648813227     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30791     Document Type: Article

References (46)

1. Grynpas MD, Marie PJ. Effects of low-doses of strontium on bone quality and quantity in rats. Bone 1990;11:313-319.
2. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:121-129.
3. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996;18:517-523.
4. Su Y, Bonnet J, Deloffre P, Tsouderos Y, Baron R. The strontium salt-S12911 inhibits the expression of carbonic-anhydrase and the vitronectin receptor in chicken bone-marrow cultures and bone-resorption in mouse calvaria and isolated rat osteoclasts. J Bone Miner Res 1992;7:S306.
5. Marie PJ. Strontium as therapy for osteoporosis. Curr Opin Pharmacol 2005;5:633-636.
6. Marie PJ, Garba MT, Hott M, Miravet L. Effect of low-doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab 1985;11:5-13.
7. Marie PJ, Hott M. Short-term effects of fluoride and strontium on bone-formation and resorption in the mouse. Metab Clin Exp 1986;35:547-551.
8. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 2001;29:176-179.
9. Dahl SG, Allain P, Marie PJ, Mauras Y, Boivin G, Ammann P, Tsouderos Y, Delmas PD, Christiansen C. Incorporation and distribution of strontium in bone. Bone 2001;28:446-453.
10. Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Mauras Y, Allain P, Tsouderos Y, Meunier PJ. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 1996;11:1302-1311.
11. Christoffersen J, Christoffersen MR, Kolthoff N, Barenholdt O. Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone 1997;20:47-54.
12. Skoryna SC. Effects of oral supplementation with stable strontium. Can Med Assoc J 1981;125:703-712.
13. Curzon MEJ, Spector PC. Strontium uptake and enamel dissolution in bovine and human-enamel. Caries Res 1983;17:249-252.
14. Mccaslin FE, Janes JM. The effect of strontium lactate in the treatment of osteoporosis. Proc Staff Meet Mayo Clin 1959;34:329-334.
15. Reginster JY, Lecart MP, Deroisy R, Lousberg C. Strontium ranelate: a new paradigm in the treatment of osteoporosis. Expert Opin Investig Drugs 2004;13:857-864.
16. Reginster JY, Deroisy R, Jupsin I. Strontium ranelate: A new paradigm in the treatment of osteoporosis. Drugs Today 2003;39:89-101.
17. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-468.
18. Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 2006;21:536-542.
19. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ. Strontium ranelate reduces the risk of non vertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab 2005;90:2816-2822.
20. Degroot K, Geesink R, Klein CPAT, Serekian P. Plasma sprayed coatings of hydroxylapatite. J Biomed Mater Res 1987;21:1375-1381.
21. Jaffe WL, Scott DF. Total hip arthroplasty with hydroxyapatite-coated prostheses. J Bone Joint Surg Am A 1996;78:1918-1934.
22. Geesink RGT, Degroot K, Klein CPAT. Chemical implant fixation using hydroxyl-apatite coatings - The development of a human total hip-prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res 1987;225:147-170.
23. Li PJ, Ducheyne P. Quasi-biological apatite film induced by titanium in a simulated body fluid. J Biomed Mater Res 1998;41:341-348.
24. Oliveira AL, Gomes ME, Malafaya PB, Reis RL. Biomimetic coating of starch based polymeric foams produced by a calcium silicate based methodology. Bioceramics 2003;240/242:101-104.
25. Oliveira AL, Elvira C, Reis RL, Vazquez B, San Roman J. Surface modification tailors the characteristics of biomimetic coatings nucleated on starch-based polymers. J Mater Sci Mater Med 1999;10:827-835.
26. Li P, Nakanishi K, Kokubo T, de Groot K. Induction and morphology of hydroxyapatite, precipitated from metastable simulated body fluids on sol-gel prepared silica. Biomaterials 1993;14:963-968.
27. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734.
28. Li PJ. Biomimetic nano-apatite coating capable of promoting bone ingrowth. J Biomed Mater Res A 2003;66:79-85.
29. Rose FRAJ, Hou QP, Oreffo ROC. Delivery systems for bone growth factors - The new players in skeletal regeneration. J Pharm Pharmacol 2004;56:415-427.
30. Luginbuehl V, Meinel L, Merkle HP, Gander B. Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm 2004;58:197-208.
31. Kraut A, Wen HB, Hippensteel E, Li PJ. A hybrid coating of biomimetic apatite and osteocalcin. J Biomed Mater Res A 2005;73:377-387.
32. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-1514.
33. Li P; DePuy Orthopaedics, Inc., assignee. Bioactive ceramic coating and method. USA Pat (2000) 6, 569, 489.
34. Li P; DePuy Products, Inc., assignee. Strontium-substituted apatite coating. USA Pat (2005) 6, 905, 723.
35. Morohashi T, Sano T, Yamada S. Effects of strontium on calcium-metabolism in rats. I. A distinction between the pharmacological and toxic doses. Jpn J Pharmacol 1994;64:155-162.
36. Marie PJ, Hott M, Modrowski D, Depollak C, Guillemain J, Deloffre P, Tsouderos Y. An uncoupling agent containing strontium prevents bone loss by depressing bone-resorption and maintaining bone-formation in estrogen-deficient rats. J Bone Miner Res 1993;8:607-615.
37. Marie PJ, Hott M. Short-term effects of fluoride and strontium on bone forming and bone resorbing cells in the mouse. Calcif Tissue Int 1986;38:S17.
38. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, Marie PJ. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 1996;18:253-259.
39. Dick WA, Tabatabai MA. Determination of orthophosphate in aqueous-solutions containing labile organic and inorganic phosphorus-compounds. J Environ Qual 1977;6:82-85.
40. -. Bone 1999;25:107S-111S.
41. Vallet-Regi M, Romero AM, Ragel CV, LeGeros RZ. XRD, SEM-EDS, and FTIR studies of in vitro growth of an apatite-like layer on sol-gel glasses. J Biomed Mater Res 1999;44:416-421.
42. Rehman I, Bonfield W. Characterization of hydroxyapatite and carbonated apatite by photo acoustic FTIR spectroscopy. J Mater Sci: Mater Med 1997;8:1-4.
43. Barralet J, Best S, Bonfield W. Carbonate substitution in precipitated hydroxyapatite: An investigation into the effects of reaction temperature and bicarbonate ion concentration. J Biomed Mater Res 1998;41:79-86.
44. Barrere F, van Blitterswijk CA, de Groot K, Layrolle P. Influence of ionic strength and carbonate on the Ca-P coating formation from SBFx5 solution. Biomaterials 2002;23:1921-1930.
45. Barrere F, van Blitterswijk CA, de Groot K, Layrolle P. Nucleation of biomimetic Ca-P coatings on Ti6Al4V from a SBF x 5 solution: Influence of magnesium. Biomaterials 2002;23:2211-2220.
46. Li P, Ohtsuki C, Kokubo T, Nakanishi K, Soga N, Nakamura T, Yamamuro T. Effects of ions in aqueous media on hydroxyapatite induction by silica gel and its relevance to bioactivity of bioactive glasses and glass-ceramics. J Appl Biomater 1993;4:221-229.